FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY FEMORAL STEM

MDR report key: 3964804 · Received July 29, 2014

Report

Report Number
1818910-2014-24366
Event Type
Injury
Date Received
July 29, 2014
Date of Event
July 8, 2014
Report Date
July 8, 2014
Manufacturer
DEPUY ORTHOPAEDICS, INC. 1818910
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

CORRECTION: MANUFACTURING FACILITY: (B)(6). SALES REP HAS REPORTED A PERIPROSTHETIC FRACTURE. THE FRACTURE WAS CABLED AND PLATED. NO IMPLANTS WERE REMOVED. DOI: (B)(6) 2014 - DOE: (B)(6) 2014 (RIGHT HIP). THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH (B)(4) APPENDIX A. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

SALES REP HAS REPORTED A PERIPROSTHETIC FRACTURE. THE FRACTURE WAS CABLED AND PLATED. NO IMPLANTS WERE REMOVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
442560 UNKNOWN DEPUY FEMORAL STEM HIP FEMORAL STEM/SLEEVE KWA DEPUY ORTHOPAEDICS, INC. 1818910 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention